These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27563870)

  • 1. Identification of a New Morpholine Scaffold as a P2Y12 Receptor Antagonist.
    Ahn YH; Lee JY; Park HD; Kim TH; Park MC; Choi G; Kim S
    Molecules; 2016 Aug; 21(9):. PubMed ID: 27563870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y
    Lei Y; Zhang B; Liu D; Zhao J; Dai X; Gao J; Mao Q; Feng Y; Zhao J; Lin F; Duan Y; Zhang Y; Bao Z; Yang Y; Mou Y; Wang S
    J Med Chem; 2020 Dec; 63(24):15752-15772. PubMed ID: 33307675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors.
    Yanachkov IB; Chang H; Yanachkova MI; Dix EJ; Berny-Lang MA; Gremmel T; Michelson AD; Wright GE; Frelinger AL
    Eur J Med Chem; 2016 Jan; 107():204-18. PubMed ID: 26588064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets.
    Gasecka A; Nieuwland R; van der Pol E; Hajji N; Ćwiek A; Pluta K; Konwerski M; Filipiak KJ
    Cardiol J; 2019; 26(6):782-789. PubMed ID: 29671861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane.
    Rabani V; Montange D; Meneveau N; Davani S
    Platelets; 2018 Nov; 29(7):709-715. PubMed ID: 29020490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.
    Ferri N; Corsini A; Bellosta S
    Drugs; 2013 Oct; 73(15):1681-709. PubMed ID: 24114622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADP receptors--targets for developing antithrombotic agents.
    Kunapuli SP; Ding Z; Dorsam RT; Kim S; Murugappan S; Quinton TM
    Curr Pharm Des; 2003; 9(28):2303-16. PubMed ID: 14529392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of ticagrelor derivatives as novel antiplatelet agents.
    Zhang H; Liu J; Zhang L; Kong L; Yao H; Sun H
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3598-602. PubMed ID: 22546677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists.
    Chao H; Turdi H; Herpin TF; Roberge JY; Liu Y; Schnur DM; Poss MA; Rehfuss R; Hua J; Wu Q; Price LA; Abell LM; Schumacher WA; Bostwick JS; Steinbacher TE; Stewart AB; Ogletree ML; Huang CS; Chang M; Cacace AM; Arcuri MJ; Celani D; Wexler RR; Lawrence RM
    J Med Chem; 2013 Feb; 56(4):1704-14. PubMed ID: 23368907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic P2Y
    Baqi Y; Müller CE
    Drug Discov Today; 2019 Jan; 24(1):325-333. PubMed ID: 30291899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
    Reiner MF; Akhmedov A; Stivala S; Keller S; Gaul DS; Bonetti NR; Savarese G; Glanzmann M; Zhu C; Ruf W; Yang Z; Matter CM; Lüscher TF; Camici GG; Beer JH
    Cardiovasc Res; 2017 Jan; 113(1):61-69. PubMed ID: 28028070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents.
    Yang W; Wang Y; Lai A; Qiao JX; Wang TC; Hua J; Price LA; Shen H; Chen XQ; Wong P; Crain E; Watson C; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
    J Med Chem; 2014 Jul; 57(14):6150-64. PubMed ID: 24931384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y
    Liu X; Gao ZG; Wu Y; Stevens RC; Jacobson KA; Zhao S
    Sci Rep; 2018 May; 8(1):8084. PubMed ID: 29795391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of P2Y receptor subtypes in platelet-derived microparticle generation.
    Kahner BN; Dorsam RT; Kunapuli SP
    Front Biosci; 2008 Jan; 13():433-9. PubMed ID: 17981558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of P2Y receptor subtypes - an update.
    von Kügelgen I
    Purinergic Signal; 2024 Apr; 20(2):99-108. PubMed ID: 37697211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response variability to P2Y12 receptor inhibitors: expectations and reality.
    Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1111-28. PubMed ID: 24262612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous Platelet P2Y12 and P2Y1 ADP Receptor Blockade: Are Two Better Than One?
    Vaduganathan M; Bhatt DL
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):427-8. PubMed ID: 26912743
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure of the human P2Y12 receptor in complex with an antithrombotic drug.
    Zhang K; Zhang J; Gao ZG; Zhang D; Zhu L; Han GW; Moss SM; Paoletta S; Kiselev E; Lu W; Fenalti G; Zhang W; Müller CE; Yang H; Jiang H; Cherezov V; Katritch V; Jacobson KA; Stevens RC; Wu B; Zhao Q
    Nature; 2014 May; 509(7498):115-8. PubMed ID: 24670650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the interaction of ticagrelor with the P2Y
    Björquist A; Di Buduo CA; Femia EA; Storey RF; Becker RC; Balduini A; Nylander S; Cattaneo M
    Thromb Haemost; 2016 Nov; 116(6):1079-1088. PubMed ID: 27605392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
    Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
    J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.